Diaphragmatic Paralysis Clinical Trial
Official title:
Effects of Inspiratory Muscle Training on Exertional Breathlessness in Patients With Unilateral Diaphragm Paralysis
NCT number | NCT04563468 |
Other study ID # | S60754 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 6, 2018 |
Est. completion date | June 13, 2022 |
Verified date | January 2023 |
Source | KU Leuven |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Treatment options for unilateral diaphragm paralysis are limited. Diaphragmatic plication via mini thoracotomy is sometimes considered in the University Hospital Leuven if severe symptoms persist for longer than 12 months after initial diagnosis. Preliminary data indicate that daily inspiratory muscle strength and endurance training can lead to increased nondiaphragmatic inspiratory muscle recruitment and help those with symptoms from diaphragmatic paralysis. Randomized controlled trials comparing intervention groups with improvements achieved by natural recovery in the first months after diagnosis are however so far lacking. The objective of the current study is therefore to investigate the effects of daily inspiratory muscle training in the first 6 months following diagnosis of unilateral diaphragmatic paralysis. The investigators hypothesize that respiratory muscle training in symptomatic patients with UDP (in comparison with a control group) will reduce symptoms of exertional dyspnea (primary outcome) and will improve respiratory muscle function (at rest and during exercise) and pulmonary function (sitting and supine).
Status | Completed |
Enrollment | 15 |
Est. completion date | June 13, 2022 |
Est. primary completion date | June 13, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria for UDP patients: - Stable, symptomatic adult UDP patients (age =18 yrs) - UDP due to presumed neuralgic amyotrophy - UDP after surgery/anesthesia (as long as there is no trauma/complete section of the phrenic nerves) - idiopathic UDP - UDP patients with Baseline Dyspnea Index (BDI) equal or lower than 9 out of 12. - UDP patients who have reduced Pi,max (<70% of predicted normal value), reduced vital capacity (<75% predicted normal value in sitting and more than 15% reduction when performed supine compared to sitting). Exclusion Criteria for UDP patients: - underlying cardiac or respiratory disease that explains symptoms of dyspnea - malignancy (i.e. metastatic lung cancer) - diagnosed psychiatric or cognitive disorders - concomitant progressive neurological, neuromuscular, or vestibular disorders - severe orthopedic problems that have a major impact on performance of functional tests Healthy adult (age =18 yrs) control subjects: - recruitement via two methods. First, friends and family of the MSc student involved in this project will be asked to participate. Secondly, posters with information about the study will be displayed in the University hospital Leuven. |
Country | Name | City | State |
---|---|---|---|
Belgium | University Hospital Leuven | Leuven |
Lead Sponsor | Collaborator |
---|---|
KU Leuven |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Dyspnea BORG category ratio 10 scale (scores from 1 to 10; higher score = worse outcome = more dyspnea) | Difference in dyspnea intensity perception on a 10-point Borg scale at comparable time points during constant work rate cycling exercise pre-post intervention between groups. | pre-post 6 months intervention | |
Secondary | Respiratory muscle function | Pi,max will be recorded using the technique proposed by Black and Hyatt. Pes,max, Pgas,max, and Pdi,max values will be obtained during maximal sniff and cough maneuvers.Twitch Pdi will also be measured after uni- and bilateral magnetic phrenic nerve stimulation. Inspiratory muscle endurance will be tested with a protocol that we have recently established. | pre-post 6 months intervention and during every supervised IMT session in the hospital | |
Secondary | Phrenic nerve conduction | Magnetic stimulation of the phrenic nerve in the neck in combination with diaphragmatic surface electromyography will be carried out to characterize phrenic nerve conduction. | pre-post 6 months intervention | |
Secondary | Maximal end endurance exercise capacity | A constant work rate (CWR) cycling test will be performed at 75% of the peak work rate achieved during a maximal incremental cardiopulmonary exercise test (CPET) to assess all main outcomes. CPET will be conducted on an electronically-braked cycle ergometer (Ergoline 800s; SensorMedics, Yorba Linda, CA) with detailed metabolic and cardiopulmonary measurements (SensorMedics Vs229d). On visit three (following IMT) two CWR tests will be performed. One until symptom limitation (tlim) and another until tlim of visit 2 to assess locomotor muscle fatigue at isotime as previously described by Amann et al. Subjects will rate intensity of breathing discomfort (dyspnea), unpleasantness of breathing, breathing-related anxiety, and leg discomfort, using the modified 10-point Borg scale. Qualitative descriptors of dyspnea will be collected at end-exercise. | pre-post 6 months intervention | |
Secondary | Respiratory effort and neural respiratory drive to the diaphragm | Pes, Pgas, Pdi and diaphragm electromyography (EMGdi) will be recorded continuously during cycle exercise using a multipair esophageal electrode catheter system. Surface EMG recordings of scalene and intercostal muscles will be performed according to a technique described by Duiverman et al. | pre-post 6 months intervention | |
Secondary | Neural respiratory drive to breathing muscles | Surface EMG recordings of scalene and intercostal muscles will be performed according to a technique described by Duiverman et al. | pre-post 6 months intervention | |
Secondary | Pulmonary function (sitting and supine position) | Spirometry and whole body plethysmography will be performed according to the European Respiratory Society guidelines for pulmonary function testing (Vs62j body plethysmograph, SensorMedics, Yorba Linda, CA). (Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.) Changes in FEV1 (L), FVC (L), FRC (L) and RV (L) will be registered. | pre-post 6 months intervention and during every supervised IMT session in the hospital | |
Secondary | Severity of dyspnea pre intervention | Assessed with Baseline throughout three categories: functional impairment, magnitude of task and magnitude of effort. A patient is asked open-ended questions regarding the symptoms. Following specific criteria, the observer is able to grade the degree of impairment (ranged 0-4) related to dyspnea for all three components. The range for the total score is 0-12. Lower score indicates a worse outcome. | pre-post 6 months intervention | |
Secondary | Change in Severity of dyspnea post intervention | Assessed with Transition Dyspnea Index (TDI) to assess changes over time. Patients report a slight, moderate or marked change, worse or better in comparison with BDI. A sum of the scores ranges between -9 and +9 where 0 indicates no change compared to baseline, a higher positive result indicates worsening of the condition and a lower negative result bigger improvement. | pre-post 6 months intervention | |
Secondary | Dyspnea during daily life | Clinical grade of breathlessness is assessed on 5 point (1 to 5) Medical Research Council Dyspnea Scale. Higher score means more dyspnea and a worse outcome. | pre-post 6 months of intervention | |
Secondary | Postural control | The participants will be asked to stand upright on a force plate. Displacements of the center of pressure (CoP) in anterior-posterior direction will be estimated from raw force plate data using the equation: CoP = Mx/Fz. Root mean square values of the CoP displacements will be used for the analysis of postural stability measures | pre-post 6 months intervention | |
Secondary | Low back pain | Disability related to low back pain will be evaluated using the Oswestry Disability Index, version 2 (adapted Dutch version) (ODI-2). A patient scores the impact of LBP on his functional ability in 10 domains of activities in daily life where each domain or item consists of 6 statements (scored 0-5). The total score is a sum ranging from 0 to 100 where higher score indicates a worse outcome (i.e. higher disability). | pre-post 6 months intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04173364 -
Interscalene Block and Dysfunction Diaphragmatic
|
Phase 3 | |
Recruiting |
NCT06243718 -
Phrenic Nerve Reconstruction for the Treatment of Diaphragmatic Paralysis: Patient Experiences and Reported Outcomes.
|
||
Active, not recruiting |
NCT06257589 -
A Chart Review to Evaluate the Safety and Efficacy of Phrenic Nerve Reconstruction for the Treatment of Diaphragmatic Paralysis
|
||
Active, not recruiting |
NCT06146179 -
Combined Anterior Suprascapular Nerve Block and Superficial Cervical Plexus Block In Shoulder Arthroplasty Surgery
|
||
Completed |
NCT05442814 -
Anterior and Posterior Approaches of Suprascapular Nerve Block
|
N/A | |
Enrolling by invitation |
NCT01569217 -
Regional Distribution of Ventilation to Assess Respiratory Muscle Dysfunction
|
N/A | |
Completed |
NCT01385384 -
Diaphragmatic Pacemaker in Tetraplegic Patients With Spinal Cord Injuries
|
N/A | |
Recruiting |
NCT05444517 -
Interscalene Block Versus Combined Infraclavicular-Anterior Suprascapular Blocks for Shoulder Surgery
|
N/A | |
Completed |
NCT03463798 -
Assesment of New Devices for the Diagnostic Evaluation of Diaphragmatic Dysfunction
|
||
Completed |
NCT03224884 -
Interscalene Block Versus Supraclavicular Block for Shoulder Surgery
|
N/A | |
Completed |
NCT00597298 -
Diaphragm Training Post-Cardiac Surgery
|
N/A | |
Completed |
NCT04317235 -
Ultrasound-guided Interscalene Block:3mL Ropi Provide Similar Analgesia to 5mL and Less Diaphragmatic Paralysis
|
N/A | |
Completed |
NCT04385966 -
Diaphragmatic Paralysis Comparison Between Local Anesthetic Volumen Doses After Interscalene Block
|
Phase 3 | |
Terminated |
NCT03592056 -
Hemidiaphragmatic Paralysis With Diluted Continuous Interscalene Plexus Infusions
|
||
Completed |
NCT03411343 -
Interscalene Block Versus Costoclavicular Block for Shoulder Surgery
|
N/A |